| GTO ID | GTC2822 |
| Trial ID | NCT05089838 |
| Disease | CMV Infection |
| Altered gene | CMV |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | CMV TCR-T cells |
| HLA | HLA-A*02:01|HLA-A*24:02|HLA-A*11:01 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Study of CMV-TCR-T Cells in the Treatment of Refractory CMV Viremia After HSCT |
| Year | 2021 |
| Country | China |
| Company sponsor | Xiao-Jun Huang |
| Other ID(s) | 2020PHD014-001 |
| Cohort 1 | |||||||||||
|
|||||||||||